Questcor Pharmaceuticals sold the Nascobal product line to QOL Medical

Oct. 2005

Client: Questcor Pharmaceuticals is a leading specialty / rare disease pharmaceutical company. Its lead product is Acthar Gel.

Role: Edgemont Partners acted as exclusive financial advisor to Questcor Pharmaceuticals in its sale of Nascobal and Ethamolin to QOL Medical

Location: Hayward, CA

Sector: Pharmaceutical Services

Lead Banker: David Blume

View Press Release